15710826

Source:http://linkedlifedata.com/resource/pubmed/id/15710826

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0038317, umls-concept:C0087111, umls-concept:C0154841, umls-concept:C1517572, umls-concept:C1656863, umls-concept:C1706817
pubmed:issue	2
pubmed:dateCreated	2005-2-15
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15710826-15710825
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7706534
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Glucocorticoids
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0003-9950
pubmed:author	pubmed-author:BlumenkranzMark SMS
pubmed:issnType	Print
pubmed:volume	123
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	259-61
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:15710826-Clinical Trials as Topic, pubmed-meshheading:15710826-Glucocorticoids, pubmed-meshheading:15710826-Humans, pubmed-meshheading:15710826-Retinal Vein Occlusion, pubmed-meshheading:15710826-Vitreous Body
pubmed:year	2005
pubmed:articleTitle	New therapy for central retinal vein occlusion: are intravitreal steroids a possible answer?
pubmed:affiliation	Department of Ophthalmology, Stanford University Medical Center, CA 94305, USA. mark.blumenkranz@stanford.edu
pubmed:publicationType	Journal Article, Comment